JP2014507390A5 - - Google Patents

Download PDF

Info

Publication number
JP2014507390A5
JP2014507390A5 JP2013544781A JP2013544781A JP2014507390A5 JP 2014507390 A5 JP2014507390 A5 JP 2014507390A5 JP 2013544781 A JP2013544781 A JP 2013544781A JP 2013544781 A JP2013544781 A JP 2013544781A JP 2014507390 A5 JP2014507390 A5 JP 2014507390A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
spinal cord
stem cells
loss
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013544781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014507390A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/065170 external-priority patent/WO2012083024A1/en
Publication of JP2014507390A publication Critical patent/JP2014507390A/ja
Publication of JP2014507390A5 publication Critical patent/JP2014507390A5/ja
Pending legal-status Critical Current

Links

JP2013544781A 2010-12-17 2011-12-15 胎盤幹細胞を用いる脊髄損傷及び外傷性脳損傷の治療 Pending JP2014507390A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061424559P 2010-12-17 2010-12-17
US61/424,559 2010-12-17
PCT/US2011/065170 WO2012083024A1 (en) 2010-12-17 2011-12-15 Treatment of spinal cord injury and traumatic brain injury using placental stem cells

Publications (2)

Publication Number Publication Date
JP2014507390A JP2014507390A (ja) 2014-03-27
JP2014507390A5 true JP2014507390A5 (https=) 2015-01-08

Family

ID=46234728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013544781A Pending JP2014507390A (ja) 2010-12-17 2011-12-15 胎盤幹細胞を用いる脊髄損傷及び外傷性脳損傷の治療

Country Status (9)

Country Link
US (1) US20120156230A1 (https=)
EP (1) EP2651451A4 (https=)
JP (1) JP2014507390A (https=)
KR (7) KR20220103812A (https=)
CN (1) CN103501822A (https=)
AU (1) AU2011343739A1 (https=)
CA (1) CA2821818A1 (https=)
MX (1) MX2013006595A (https=)
WO (1) WO2012083024A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2666503T3 (es) * 2012-05-16 2018-05-04 Becton, Dickinson And Company Características distintivas de superficie celular para aislar neuronas de cultivos celulares derivados de células madre pluripotentes
JP2015521630A (ja) * 2012-06-26 2015-07-30 ラスティー プロパティー ホールディングス プロプライエタリー リミテッド 頭痛の頻度および/または重症度を下げるための組成物および方法
WO2014022427A1 (en) * 2012-08-02 2014-02-06 Bioaxone Biosciences Inc. Inhibition of rho and or rock and cell transplantation
US20160120909A1 (en) * 2013-05-10 2016-05-05 Cell-Innovations Ip Pty Ltd Compositions And Methods For The Treatment Of Tinnitus
WO2015023901A1 (en) * 2013-08-15 2015-02-19 The Regents Of The University Of California Placenta-derived multipotent stem cells
JP7109160B2 (ja) 2014-06-18 2022-07-29 ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー 神経外傷性障害において第xii因子インヒビターを使用する療法
US10493105B2 (en) * 2014-09-11 2019-12-03 Taiwan Mitochondrion Applied Technology Co., Ltd Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
GB201518263D0 (en) * 2015-10-15 2015-12-02 Oxford Bioelectronics Ltd Method
WO2017152035A1 (en) * 2016-03-03 2017-09-08 Henry Ford Health System 3-d collagen scaffold-generated exosomes and uses thereof
CA3046078A1 (en) * 2016-12-05 2018-06-14 Celularity Inc. Treatment of lymphedema and related conditions using placental adherent cells
US20200246386A1 (en) * 2017-04-24 2020-08-06 Pluristem Ltd. Methods and compositions for treating neurological disorders
US20180322956A1 (en) * 2017-05-05 2018-11-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Time Window-Based Platform for the Rapid Stratification of Blunt Trauma Patients into Distinct Outcome Cohorts
EP3630963A1 (en) 2017-05-30 2020-04-08 BioAxone BioSciences, Inc. C3 fusion protein and methods of making and using thereof
CN107227521B (zh) * 2017-08-09 2023-03-14 青岛金汇丰机械有限公司 一种五轴毛纺粗纱机
KR20190048894A (ko) 2017-10-31 2019-05-09 경상대학교산학협력단 Jnk 활성 억제제를 유효성분으로 포함하는 퇴행성 신경질환의 예방 또는 치료용 약학적 조성물
CN108413478A (zh) * 2018-02-11 2018-08-17 广东美的环境电器制造有限公司 一种控制方法、装置及计算机可读存储介质
KR102070403B1 (ko) 2019-09-06 2020-01-28 경상대학교 산학협력단 Jnk 활성 억제제를 유효성분으로 포함하는 외상성 뇌손상의 치료용 약학적 조성물
CN114561355B (zh) * 2022-01-23 2023-04-11 四川大学华西医院 一种脊髓瘢痕组织细胞急性快速分离方法
CN117274869B (zh) * 2023-09-25 2024-03-26 北方工业大学 一种基于形变场提取的细胞形变动态分类方法及系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US20080152629A1 (en) * 2000-12-06 2008-06-26 James Edinger Placental stem cell populations
PT2471904T (pt) * 2005-12-29 2019-02-25 Celularity Inc População de células estaminais placentárias
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
EP3763376A1 (en) * 2007-02-12 2021-01-13 Celularity, Inc. Treatment of inflammatory diseases using placental stem cells
US20090214484A1 (en) * 2008-02-22 2009-08-27 Nikolay Mironov Stem cell therapy for the treatment of central nervous system disorders
WO2010021715A1 (en) * 2008-08-20 2010-02-25 Anthrogenesis Corporation Treatment of stroke using isolated placental cells
AU2009316541B2 (en) * 2008-11-19 2015-08-06 Celularity Inc. Amnion derived adherent cells

Similar Documents

Publication Publication Date Title
JP2014507390A5 (https=)
Ladenbauer et al. Brain stimulation during an afternoon nap boosts slow oscillatory activity and memory consolidation in older adults
Hugdahl Symmetry and asymmetry in the human brain
Small et al. Brain repair after stroke—a novel neurological model
Prehn-Kristensen et al. Sleep restores daytime deficits in procedural memory in children with attention-deficit/hyperactivity disorder
Beghi et al. Idiopathic generalized epilepsies of adolescence
Barber Evoked Potentials: Proceedings of an International Evoked Potentials Symposium Held in Nottingham, England
RU2678979C2 (ru) Средство для использования в гомеопатической технологии
Lüttjohann et al. Electrical stimulation of the epileptic focus in absence epileptic WAG/Rij rats: assessment of local and network excitability
Jambaqué et al. Cognitive disorders in pediatric epilepsy
RU2013108868A (ru) Способы лечения и/или реверсии нейродегенеративных заболеваний и/или расстройств
Littlejohn et al. Fibromyalgia syndrome: which antidepressant drug should we choose
Gaudreault et al. Abnormal occipital event-related potentials in Parkinson's disease with concomitant REM sleep behavior disorder
Reilly et al. Neuromodulation of cursing in American English: A combined tDCS and pupillometry study
Drago et al. Artistic creativity and DBS: a case report
Brukamp et al. Neuroenhancement-a controversial topic in contemporary medical ethics
El Shennawy et al. Electrophysiologic assessment of auditory function in children with autism and attentiondeficit and hyperactivity disorder
Lindsay Can hyper-synchrony in meditation lead to seizures? Similarities in meditative and epileptic brain states
RICHARDS The influence of environmental sound on attention control and gait in older adults
Coles Temporal lobe epilepsy and Dostoyevsky seizures: Neuropathology and Spirituality
Ashibokova et al. Interdisciplinary approach (neurologist and psychiatrist) in the treatment of chronic tension-type headaches
Rothstein The neural correlates of early identity and expression processing
MX2019013717A (es) Plasma de origen animal o fracciones del mismo para usarse en el tratamiento contra trastornos del deterioro cognitivo en humanos y animales de compañia.
Kislova et al. Characteristics of EEG in Subjects with High Level of Identification of Emotions in Speech.
Korenar Landau-Kleffner syndrome and swearing